Loading clinical trials...
Loading clinical trials...
A Single-Blind Dose-Ranging Study in Subjects With Neurogenic Orthostatic Hypotension to Evaluate the Effect of CST-3056 on Symptoms and Signs of Orthostatic Hypotension
Conditions
Interventions
CST-3056
Placebo
Locations
4
United States
CuraSen Investigational Site
Farmington Hills, Michigan, United States
CuraSen Investigational Site
Eatontown, New Jersey, United States
CuraSen Investigational Site
New York, New York, United States
CuraSen Investigational Site
Nashville, Tennessee, United States
Start Date
September 12, 2025
Primary Completion Date
March 31, 2026
Completion Date
March 31, 2026
Last Updated
February 27, 2026
NCT04620382
NCT01799915
NCT06751888
NCT02784535
NCT03229174
NCT00977171
Lead Sponsor
CuraSen Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions